within Pharmacolibrary.Drugs.ATC.C;

model C07AB06
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.5,
    Cl             = 400 / 1000 / 60,
    adminDuration  = 600,
    adminMass      = 200 / 1000000,
    adminCount     = 1,
    Vd             = 0.0032,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.004166666666666667,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Bevantolol is a non-selective beta-adrenergic blocker once used mainly for the management of hypertension and angina pectoris. It is a beta blocker with mild intrinsic sympathomimetic activity, but it is not widely marketed or available in many countries today and is not an approved or commonly prescribed medication currently.</p><h4>Pharmacokinetics</h4><p>Typical estimated pharmacokinetic parameters for an adult (assumed healthy) population based on class-related properties and limited available data; no direct clinical PK studies with detailed modeling found for bevantolol.</p><h4>References</h4><ol><li><p>Toothaker, RD, et al., &amp; Goulet, JR (1987). The influence of food on the oral absorption of bevantolol. <i>Journal of clinical pharmacology</i> 27(4) 297–299. DOI:<a href=&quot;https://doi.org/10.1002/j.1552-4604.1987.tb03017.x&quot;>10.1002/j.1552-4604.1987.tb03017.x</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2890668/&quot;>https://pubmed.ncbi.nlm.nih.gov/2890668</a></p></li><li><p>Latts, JR (1986). Clinical pharmacokinetics and metabolism of bevantolol. <i>Angiology</i> 37(3 Pt 2) 221–225. DOI:<a href=&quot;https://doi.org/10.1177/000331978603700313&quot;>10.1177/000331978603700313</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2871781/&quot;>https://pubmed.ncbi.nlm.nih.gov/2871781</a></p></li><li><p>Selen, A, et al., &amp; Welling, PG (1986). Comparative single dose and steady-state pharmacokinetics of bevantolol in young and elderly subjects. <i>European journal of clinical pharmacology</i> 30(6) 699–704. DOI:<a href=&quot;https://doi.org/10.1007/BF00608218&quot;>10.1007/BF00608218</a>  PUBMED:<a href=&quot;https://pubmed.ncbi.nlm.nih.gov/2876899/&quot;>https://pubmed.ncbi.nlm.nih.gov/2876899</a></p></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end C07AB06;
